Contact Us
Drug Search Results
More Filters [+]

CNTO-2476

Alternative Names: cnto-2476, cnto 2476, cnto2476
Latest Update: 2020-08-21
Latest Update Note: News Article

Product Description

For Advanced Retinitis Pigmentosa (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00458575)

Mechanisms of Action: Cell Therapy

Novel Mechanism: No

Modality: Cell Therapy

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Johnson & Johnson
Company Location: NEW BRUNSWICK NJ 08933
Company CEO: Joaquin Duato
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CNTO-2476

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Geographic Atrophy|Macular Degeneration

Phase 1: Retinitis Pigmentosa

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
JapicCTI-163414

P2

Terminated

Geographic Atrophy|Macular Degeneration

2021-02-20

CR108188

P2

Withdrawn

Geographic Atrophy|Macular Degeneration

2021-02-20

PRELUDE

P2

Completed

Macular Degeneration|Geographic Atrophy

2019-06-05

CR017548

P2

Completed

Geographic Atrophy|Macular Degeneration

2015-03-31

Recent News Events

Date

Type

Title

08/21/2020

News Article

 Global Geographic Atrophy Industry Assessment and Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions